Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic

Background: Beta-blockers have been shown to decrease mortality and morbidity in heart failure with reduced ejection fraction (HFrEF) patients. However, the side effects are also dose-related, leading to the underdosing. Cost constraint may be one of the limitations of appropriate beta-blocker use;...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanchai, Rattanachai, Kanjanavanit, Rungsrit, Leemasawat, Krit, Amarittakomol, Anong, Topaiboon, Paleerat, Phrommintikul, Arintaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Cardiovascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769774/
https://www.ncbi.nlm.nih.gov/pubmed/29379674
http://dx.doi.org/10.1080/21556660.2018.1423988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769774/
https://www.ncbi.nlm.nih.gov/pubmed/29379674
http://dx.doi.org/10.1080/21556660.2018.1423988

Ejemplares similares